Ignite Creation Date:
2024-05-05 @ 10:34 PM
Last Modification Date:
2024-10-26 @ 10:20 AM
Study NCT ID:
NCT01134939
Status:
COMPLETED
Last Update Posted:
2015-01-21
First Post:
2010-06-01
Brief Title:
Non-interventional Observational Study With Viramune in HIV to Evaluate Gender Specific Data
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
Non-interventional Observational Study With Viramune Plus Antiretroviral Backbone Combination in HIV-infected Women and Male Patients Gender Specific Evaluation of Data
Status:
COMPLETED
Status Verified Date:
2015-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The question that prompted this study is the extent to which results from clinical trials can be translated into everyday practice external validity First and foremost are questions about tolerability and the efficacy of an antiretroviral combination treatment with Viramune and other antiretroviral partners In particular adverse events will be recorded depending on gender and the therapeutic effect will be monitored via the course of viral load and improvement of the immune system based on the CD4 cell count
Detailed Description:
Time Perspective
retro- and prospective
retro- and prospective
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None